Warning: The NCBI web site requires JavaScript to function. more...
Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples.
Zanetti-Dällenbach R, Vuaroqueaux V, Wight E, Labuhn M, Singer G, Urban P, Eppenberger U, Holzgreve W, Eppenberger-Castori S.
Breast Cancer Res. 2006;8(4):R51.
Related citations
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z.
BMC Cancer. 2007 Mar 27;7:55.
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
Gianni L, Zambetti M, Clark K, Baker J, Cronin M, Wu J, Mariani G, Rodriguez J, Carcangiu M, Watson D, Valagussa P, Rouzier R, Symmans WF, Ross JS, Hortobagyi GN, Pusztai L, Shak S.
J Clin Oncol. 2005 Oct 10;23(29):7265-77. Epub 2005 Sep 6.
Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ.
Clin Cancer Res. 2006 Oct 1;12(19):5705-12.
Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study.
Espinosa E, Vara JA, Redondo A, Sánchez JJ, Hardisson D, Zamora P, Pastrana FG, Cejas P, Martínez B, Suárez A, Calero F, Barón MG.
J Clin Oncol. 2005 Oct 10;23(29):7278-85. Epub 2005 Aug 29.
Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.
Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L.
Cancer. 2003 Jun 15;97(12):2960-71.
Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.
André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S.
Lancet Oncol. 2009 Apr;10(4):381-90. Epub 2009 Feb 25.
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.
Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, Chen YY, Chew KL, Dairkee SH, Jensen RM, Waldman FM.
Cancer Res. 2003 Nov 1;63(21):7167-75.
[Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM, Li XQ, Sun BC, Gao XC, Gu L, Niu Y, Hao XS.
Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Chinese.
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.
Mina L, Soule SE, Badve S, Baehner FL, Baker J, Cronin M, Watson D, Liu ML, Sledge GW Jr, Shak S, Miller KD.
Breast Cancer Res Treat. 2007 Jun;103(2):197-208. Epub 2006 Oct 13.
Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
Mohammad AM, Abdel HA, Abdel W, Ahmed AM, Wael T, Eiman G.
Indian J Cancer. 2006 Oct-Dec;43(4):163-8.
A resampling-based meta-analysis for detection of differential gene expression in breast cancer.
Gur-Dedeoglu B, Konu O, Kir S, Ozturk AR, Bozkurt B, Ergul G, Yulug IG.
BMC Cancer. 2008 Dec 30;8:396.
ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.
Seniski GG, Camargo AA, Ierardi DF, Ramos EA, Grochoski M, Ribeiro ES, Cavalli IJ, Pedrosa FO, de Souza EM, Zanata SM, Costa FF, Klassen G.
BMC Cancer. 2009 Mar 6;9:80.
Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.
Lyng MB, Laenkholm AV, Pallisgaard N, Vach W, Knoop A, Bak M, Ditzel HJ.
Cell Oncol. 2007;29(5):361-72.
Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer.
Sgouros J, Galani E, Gonos E, Moutsatsou P, Belechri M, Skarlos D, Dionyssiou-Asteriou A.
In Vivo. 2007 May-Jun;21(3):519-22.
Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K.
BMC Cancer. 2008 Sep 8;8:254.
Radiation-associated breast tumors display a distinct gene expression profile.
Broeks A, Braaf LM, Wessels LF, van de Vijver M, De Bruin ML, Stovall M, Russell NS, van Leeuwen FE, Van 't Veer LJ.
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):540-7.
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
Breast Cancer Res. 2008;10(5):R87. Epub 2008 Oct 17.
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers.
Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera GV, Wu Y, Pusztai L, Symmans WF.
J Natl Cancer Inst. 2011 Dec 21;103(24):1871-83. Epub 2011 Oct 27.
Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y, Qian Y, Wei L, Abraham J, Shi X, Castranova V, Harner EJ, Flynn DC, Guo L.
Clin Cancer Res. 2007 Apr 1;13(7):2014-22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on